What's happening
This bill requires written disclosure of the likelihood and data on false-positive results for all prenatal tests in New York.
Why it matters
Increases transparency and patient understanding. by requiring clear, written disclosure of false-positive rates and supporting data for each prenatal test, helping expectant parents make better-informed decisions about testing.
Limits use of insufficiently validated tests. by prohibiting the offering of tests for conditions if the necessary false-positive data cannot be obtained, potentially reducing patient anxiety and the risk of acting on unreliable results.
Mandates standardized communication. by having the Department of Health develop the written notice and ensuring it is plainly worded, consistently provided before testing, with results, and in all related materials, so information is accessible and not buried in fine print.
Protects clinician judgment. by clarifying that healthcare providers retain the ability to recommend specific prenatal tests based on their professional assessment of a patient’s needs, maintaining flexibility for unique medical situations.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Pregnant patients and potential parents
They would receive written information about false-positive results before prenatal testing and with test results.
Prenatal test manufacturers, suppliers and advertisers
They would have to provide department-developed notices stating the percentage of positive results that are false positives and include those notices with testing materials.
Hospitals and prenatal care providers
They would have to provide notices unless the test entity already does so, and generally could not offer testing for a condition without the required laboratory data, subject to an exception for patient-requested testing.
New York State Department of Health
It would develop plainly worded notices that include all laboratory data used to determine false-positive results.
Headline styles
Disclose False Prenatal Positives
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Require Prenatal Test Warnings
In Senate Committee · Rules · Sponsor James Skoufis
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
9413
IN ASSEMBLY
March 3, 2022
Introduced by M. of A. GRIFFIN -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to requiring a written notice on the occurrence of a false-positive result for any condition tested during a prenatal test
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2533 to read as follows:
§ 2533. Disclosure of information concerning prenatal testing. a. The following terms as used in this section shall mean the following:
1. "Laboratory" shall have the same meaning as is set forth in section five hundred seventy-one of this chapter.
2. "Prenatal testing services" means any service provided by a hospital to identify potential problems with a pregnancy or the relative likelihood of abnormalities in a fetus. Such services shall include but not be limited to services that test placental tissue or the blood of a pregnant patient.
3. "Material" means any advertisement, promotional brochure, website or documentation that may be presented to a patient or a potential parent to recommend prenatal testing services offered by a hospital.
4. "Percentage of positives being a false-positive" means the ratio of the number of false-positive results divided by the sum of the number of false-positive results and the number of true positives.
b. Every prenatal test shall include a written notice, provided by the entity which manufactured, supplied, or otherwise created such test or which advertised performing prenatal tests, about the occurrence of a false-positive result, including but not limited to the percentage of positives being a false-positive, for any condition tested during such prenatal test. Such written notice shall be provided to a patient or a potential parent: (i) prior to any prenatal test; (ii) with such test results; and (iii) with any materials provided by the entity providing or facilitating the prenatal testing. Such written notice shall be developed by the department and shall include all data used by a labora-
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14192-06-2
tory to determine such false-positive results. If such data cannot be obtained for a condition tested during a prenatal test from the laboratory, such condition shall not be offered to a patient or a potential parent to be included in the prenatal testing services. Such written notice shall be plainly worded and prominently displayed in any material presented to a patient or a potential parent about prenatal testing services.
c. Every hospital or health care provider offering prenatal testing services shall provide a written notice about the occurrence of a falsepositive result, which may include the percentage of positives being a false-positive as required under subdivision b of this section, for any condition tested during such prenatal test; provided, however, such notice shall not be required if such notice is provided to the patient or potential parent by the entity which manufactured, supplied, or otherwise created such test or which advertised performing prenatal tests under subdivision b of this section. Such written notice shall be provided to a patient or a potential parent prior to any prenatal test and when a patient or a potential parent receives such test results. Such written notice shall be developed by the department and shall include all data used by a laboratory to determine such false-positive results. If such data cannot be obtained for a condition tested during a prenatal test from the laboratory, such condition shall not be offered to a patient or a potential parent to be included in the prenatal testing services. Such written notice shall be plainly worded and prominently displayed in any material presented to a patient or a potential parent about prenatal testing services.
d. Notwithstanding the provision of subdivision b or c of this section, if prior to receiving material from an entity or hospital on the prenatal testing services offered by such entity or hospital a patient requests a certain condition to be tested during the prenatal test, such condition shall be tested for if such test is available. When a patient receives the results of such prenatal test, if there is data on any condition tested such data shall be provided to the patient pursuant to subdivision b or c of this section.
e. Nothing contained in this section shall be construed to limit a health care practitioner licensed, certified, or authorized under title eight of the education law from recommending certain prenatal testing services according to the practitioner's reasonable and good faith professional judgment based on the facts of a patient's case.
§ 2. This act shall take effect on the thirtieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.